May 8, 2019 Price forecast | 2 weeks: 0.56% | 1 month: 1.23% | 3 months: 0.84%


EXEL stock forecast

Our latest prediction for Exelixis, Inc.'s stock price was made on the May 8, 2019 when the stock price was at 20.32$.

In the short term (2weeks), EXEL's stock price should outperform the market by 0.56%. During that period the price should oscillate between -5.10% and +9.53%.

In the medium term (3months), EXEL's stock price should outperform the market by 0.84%. During that period the price should oscillate between -13.35% and +29.33%.


About Exelixis, Inc.

Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in Alameda, CA.

At the moment the company generates 910M USD in revenues.

On its last earning announcement, the company reported a profit of 2.04$ per share.

The book value per share is 2.60$

Exelixis, Inc. website


Three months stock forecastMay 8, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
910M 96.70% 413M 45.40% 642M 2.04 - - 314M 2.60 563M -22M 541M